This company develops precision drug dosing platforms that optimize medication delivery based on individual patient needs. Their technology aims to improve treatment outcomes and reduce adverse effects by tailoring dosages to specific patient characteristics.
Funding
Funding not disclosed
Founders
Product
Problem
Imprecise drug dosing leads to significant adverse patient outcomes, including over 9,000 deaths and 1.3 million patient injuries annually, contributing to over $40 billion in healthcare costs. Current methods often fail to account for individual patient variability, resulting in suboptimal medication delivery.
Solution
Hikari Medical Technologies develops a non-invasive precision drug dosing platform designed to optimize medication delivery based on individual patient needs. Their technology enables real-time drug monitoring, allowing for tailored dosages that improve treatment efficacy and reduce adverse effects. The platform aims to provide a critical competitive advantage by offering a solution that adapts to specific patient characteristics, ensuring safer and more effective drug administration.
Target Audience
The primary target audience includes healthcare providers and pharmaceutical companies seeking to improve patient safety and treatment outcomes through personalized drug dosing strategies.
Features
- Non-invasive drug monitoring technology
- Real-time dosage adjustments based on patient-specific data
- Platform technology applicable to various drug types and patient populations